Ventricular Tachycardia: Clinical Trials

16 trials for Ventricular Tachycardia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 3 terminated, 3 unknown, 1 active not recruiting. 16 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 416Completed 9, Terminated 3, Unknown 3, Active not recruiting 1

Follow Ventricular Tachycardia: new trials by email Literature Review of Ventricular Tachycardia trials Research Report on Ventricular Tachycardia

Trials (filtered) newest first · largest first

All 16 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ventricular Tachycardia Ablation and Myocardial Scar Characterization With Magnetic Resonance
Group 1, CMR-guided/aided VT ablation, Group 2, CMR-aided VT ablation, Group 3, Electroanatomical guided ablation - Ventricular Tachycardia, Myocardial Fibrosis
Phase 4CompletedAzienda Ospedaliero, Universitaria Pisana1042020-08-032025-12-15
Targeted Potassium Levels for Prevention of ICD Therapy
Targeted serum potassium level - Ventricular Arrhythmias and Cardiac Arrest, Implantable Defibrillator User
Phase 4Active not recruitingCopenhagen University Hospital, Rigshospitalet12002019-03-012025-05-09
Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.
Nifekalant hydrochloride, Amiodarone - Ventricular Tachycardia, Ventricular Fibrillation
Phase 4UnknownSichuan Baili Pharmaceutical Co., Ltd.7562019-01-152019-02-27
DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation
DOAC, Aspirin - Ventricular Tachycardia, Premature Ventricular Contraction
Phase 4CompletedKansas City Heart Rhythm Institute2462017-02-162022-08-22
Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
Antiarrhythmic Drug Therapy, Catheter ablation - Ventricular Tachycardia, Ventricular Arrhythmia
Phase 4TerminatedOttawa Heart Institute Research Corporation32014-10-012026-05-04
Ultra-high Density Mapping With Multielectrode Catheter vs Conventional Point by Point Mapping for Ventricular Tachycardia Substrate Ablation
Ablation guided by conventional mapping., Ablation guided by ultra-high density mapping with multielectrode catheter. - Ventricular Tachycardia
Phase 4CompletedHospital Clinic of Barcelona202014-04-012017-02-27
Catheter Ablation Versus Antiarrhythmic Drugs for Outflow Tract Ventricular ARrhythmias
antiarrhythmic drugs (Flecainide or Propafenone or Sotalol), Catheter Ablation - Ventricular Tachycardia, Ventricular Premature Complexes
Phase 4UnknownOspedale San Donato2013-01-012013-01-31
Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
Drug Treatment, Catheter Ablation - Ventricular Tachycardia, Ischemic
Phase 4TerminatedBiosense Webster, Inc.152012-06-012017-06-08
Safety of Amiodarone and Ranolazine Together in Patients With Angina
ranolazine, placebo - Chronic Stable Angina, Coronary Artery Disease
Phase 4UnknownCardiovascular Consultants of Nevada502012-01-012012-03-21
Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia
Magnetic irrigated ablation catheter - Ventricular Tachycardia
Phase 4CompletedStereotaxis532009-06-012015-08-24
The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock
Dual Chamber ICD, Single Chamber ICD - Ventricular Tachycardia, Ventricular Fibrillation
Phase 4CompletedMayo Clinic1002008-11-012014-07-24
Influence of Home Monitoring on the Clinical Status of Heart Failure Patients With an Impaired Left Ventricular Function
ICD or CRT-D with Home Monitoring feature deactivated, ICD or CRT-D with Home Monitoring feature activated - Ventricular Fibrillation, Ventricular Tachycardia
Phase 4CompletedBiotronik SE & Co. KG7202007-07-012014-12-23
Catheter Evaluation for Endocardial Ablation in Patients With Ventricular Tachycardia
NAVISTAR® THERMOCOOL® Catheter - Ventricular Tachycardia
Phase 4CompletedBiosense Webster, Inc.2492007-01-012025-02-04
Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia
iv Amiodarone, iv Procainamide - Ventricular Tachycardia, Wide QRS Tachycardia
Phase 4TerminatedHospital General Universitario Gregorio Marañon3022005-09-012016-04-06
Remote Follow-up of Patients Receiving Implantable Cardioverter Defibrillator for Prophylactic Therapy
Implantable Cardioverter Defibrillator - Ventricular Fibrillation, Ventricular Tachycardia
Phase 4CompletedBiotronik SE & Co. KG1552004-01-012011-01-17
Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)
amiodarone beta blocker sotalol - Ventricular Tachycardia
Phase 4CompletedConnolly, Stuart, M.D.4002001-01-012006-07-27

Narrower conditions

Tachycardia, Ventricular (16)  ·  Ventricular Fibrillation (4)  ·  Arrhythmias, Cardiac (3)  ·  Atrial Fibrillation (3)  ·  Ventricular Premature Complexes (2)  ·  Angina, Stable (1)  ·  Coronary Artery Disease (1)  ·  Heart Arrest (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Hyperkalemia (1)  ·  Hypokalemia (1)  ·  Ischemia (1)  ·  Stroke (1)  ·  Tachycardia, Supraventricular (1)

Broader conditions

Cardiac Conduction System Disease (16)  ·  Cardiovascular Diseases (16)  ·  Pathologic Processes (16)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Tachycardia (16)  ·  Heart Diseases (15)  ·  Arrhythmias, Cardiac (13)  ·  Cardiac Complexes, Premature (2)  ·  Vascular Diseases (2)  ·  Angina Pectoris (1)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)

Interventions

Amiodarone (3)  ·  Catheter Ablation (3)  ·  Defibrillators, Implantable (2)  ·  Procainamide (2)  ·  Sotalol (2)  ·  Anti-Arrhythmia Agents (1)  ·  Aspirin (1)  ·  Dabigatran (1)  ·  Flecainide (1)  ·  Injections (1)  ·  Mexiletine (1)  ·  Propafenone (1)  ·  Ranolazine (1)  ·  Rivaroxaban (1)  ·  edoxaban (1)

Sponsors

Biosense Webster, Inc. (2)  ·  Biotronik SE & Co. KG (2)  ·  Azienda Ospedaliero, Universitaria Pisana (1)  ·  Cardiovascular Consultants of Nevada (1)  ·  Connolly, Stuart, M.D. (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Hospital Clinic of Barcelona (1)  ·  Hospital General Universitario Gregorio Marañon (1)  ·  Kansas City Heart Rhythm Institute (1)  ·  Mayo Clinic (1)  ·  Ospedale San Donato (1)  ·  Ottawa Heart Institute Research Corporation (1)  ·  Sichuan Baili Pharmaceutical Co., Ltd. (1)  ·  Stereotaxis (1)

Countries

United States (5)  ·  Czechia (3)  ·  Germany (3)  ·  Canada (2)  ·  Denmark (2)  ·  Israel (2)  ·  Italy (2)  ·  Spain (2)  ·  Australia (1)  ·  Austria (1)  ·  China (1)  ·  India (1)  ·  Latvia (1)

Top investigators

Gerhard Hindricks, Prof. Dr. (2)  ·  Andrea Natale, MD (1)  ·  Blanca Coll-Vinent, MD (1)  ·  Carmen del Arco, MD (1)  ·  Christian Joens, MD, PhD (1)  ·  David Callans, MD (1)  ·  David Wilber, MD (1)  ·  Dhanunjaya Lakkireddy, MD (1)  ·  Diego Penela, MD (1)  ·  Dolores Vigil, MD (1)  ·  Erik J SIrulnick, MD (1)  ·  Fernando Arribas, MD (1)  ·  Francis Marchlinski, MD (1)

Results publications

PMID 16403928, PMID 16818810, PMID 23868932, PMID 25131977, PMID 26868693, PMID 35421939, PMID 37467227, PMID 40879429, PMID 41923135

NIH funding

2005 (1)